Basic info
Industry
pharmaceutical manufacturing
Sectors
Hepatic fibrosis
Biotechnology
Liver disease
Drug R&D
Pharmaceutical
Disease prevention
Liver cancer
Health Care
Precision medicine
Translational medicine
Antivirals
Innovative therapeutics
HCV
Drug discovery
NAFLD/NASH
HBV
Cancer
Date founded
2014
Funding rounds raised
Total raised
$5.2M
from 1 investors over 1 rounds
H
Hepanova, Inc. raised $5.2M on January 30, 2019
Investors: Shenzhen Capital Group Co., Ltd